HIV Medicine

PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection
pp. 591-613(23)

Smoking cessation in HIV patients: rate of success and associated factors
pp. 614-619(6)
Authors: Fuster, M; Estrada, V; Fernandez-Pinilla, MC; Fuentes-Ferrer, ME; Tellez, MJ; Vergas, J; Serrano-Villar, S; Fernandez-Cruz, A

Identification of new genotypic cut-off levels to predict the efficacy of lopinavir/ritonavir and darunavir/ritonavir in the TITAN trial
pp. 620-626(7)
Authors: Hill, A; Marcelin, A-G; Calvez, V

Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV-1-infected individuals receiving combination antiretroviral therapy
pp. 627-633(7)
Authors: Kristoffersen, US; Kofoed, K; Kronborg, G; Benfield, T; Kjaer, A; Lebech, A-M

Laryngeal squamous cell carcinoma in HIV-positive patients: lack of association with human papillomavirus infection
pp. 634-639(6)
Authors: Moyano, S; Ordi, J; Caballero, M; Garcia, F; Diaz, A; de Sanjose, S; Cardesa, A; Alos, L

Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire
pp. 640-646(7)
Authors: Diabaté, S; Alary, M

Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS)
pp. 647-656(10)
Authors: Scherrer, AU; Hasse, B; von Wyl, V; Yerly, S; Böni, J; Bürgisser, P; Klimkait, T; Bucher, HC; Ledergerber, B; Günthard, HF

Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART
pp. 657-660(4)
Authors: Taiwo, BO; Li, X; Palella, F; Jacobson, LP; Margolick, JB; Detels, R; Rinaldo, CR; Phair, JP

ERRATUM
pp. 661-661(1)

A note of thanks to referees for Volume 10, 2009
pp. 662-665(4)